University R&D Funding Strategies in a Changing Federal Funding Environment

Published in: Science and Public Policy, 2014

Posted on on January 01, 2014

by Margaret E. Blume-Kohout, Krishna B. Kumar, Neeraj Sood

This paper evaluates how changes in US National Institutes of Health (NIH) funding levels affected US universities' total biomedical R&D efforts, over a period of dramatic change in the federal funding environment. Instrumental variables estimation reveals that during the NIH budget doubling period (1998–2003), each federal dollar that US universities received spurred an additional $0.26 in research support from non-federal sources, with stronger complementarity found among historically less-research-intensive institutions. However, in the more competitive post-doubling environment (2006 onwards), the more research-intensive PhD-granting universities substituted funding from non-federal sources to maintain stable levels of R&D expenditures. In contrast, at non-PhD-granting and historically less-research-intensive institutions, total R&D funding and expenditures declined overall with reduced availability of federal funds. However, the effect of successful federal applications on subsequent non-federal investment remained significant and positive for this latter group, suggesting federal R&D funding may play an important signaling role.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.